Pre-earnings options volume in Edwards Lifesciences (EW) is 2.9x normal with puts leading calls 9:2. Implied volatility suggests the market is anticipating a move near 5.5%, or $4.18, after results are released. Median move over the past eight quarters is 6.8%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Is EW a Buy, Before Earnings?
- Edwards Lifesciences files automatic mixed securities shelf
- Edwards Lifesciences price target raised to $87 from $85 at Mizuho
- Edwards Lifesciences price target raised to $81 from $75 at Morgan Stanley
- Cautious Outlook for Edwards Lifesciences Amidst TAVR Sales Challenges and Market Share Concerns